Oct 30, 2014
|
MacroGenics to Present Pre-Clinical Data on MGD006 at 26th EORTC-NCI-AACR Symposium
|
|
Oct 28, 2014
|
MacroGenics Announces Date of Third Quarter 2014 Financial Results Conference Call
|
|
Sep 29, 2014
|
MacroGenics and Takeda Enter Second Strategic Alliance to Develop Multiple Additional DART Therapeutics
|
|
Aug 06, 2014
|
MacroGenics to Present at the Wedbush 2014 Life Sciences Management Access Conference
|
|
Aug 05, 2014
|
MacroGenics Provides Update on Corporate Progress and Second Quarter 2014 Financial Results
|
|
Jul 29, 2014
|
MacroGenics Announces Date of Second Quarter 2014 Financial Results Conference Call
|
|
Jul 24, 2014
|
MacroGenics' DART Candidate IND for Colorectal Cancer, MGD007, Cleared to Start Enrolling Patients
|
|
Jun 19, 2014
|
MacroGenics Initiates Phase 1 Study of MGD006 for the Treatment of Acute Myeloid Leukemia
|
|
May 27, 2014
|
MacroGenics and Takeda Enter Strategic Alliance to Develop DART for Treatment of Autoimmune Disorders
|
|
May 07, 2014
|
MacroGenics to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
|
|
May 06, 2014
|
MacroGenics Provides Update on Corporate Progress and First Quarter 2014 Financial Results
|
|
May 05, 2014
|
MacroGenics Presents Pre-Clinical Data on Inhibition of Autoimmune Diseases With DART Candidate MGD010 at IMMUNOLOGY 2014
|
|
Apr 30, 2014
|
MacroGenics Appoints Atul Saran as Senior Vice President and General Counsel
|
|
Apr 29, 2014
|
MacroGenics Announces Date of First Quarter 2014 Financial Results Conference Call
|
|
Apr 28, 2014
|
MacroGenics to Present Pre-Clinical Data on Novel DART Candidate MGD010 for Autoimmune Disorders at IMMUNOLOGY 2014
|
|
Apr 06, 2014
|
MacroGenics Presents Pre-Clinical Data Demonstrating Potent Activity With Colorectal Cancer Product Candidate MGD007 at the AACR Annual Meeting
|
|
Apr 01, 2014
|
MacroGenics to Present at the 13th Annual Needham Healthcare Conference
|
|
Mar 31, 2014
|
MacroGenics to Present Pre-clinical Data on MGD007 at the AACR Annual Meeting
|
|
Mar 20, 2014
|
MacroGenics Provides Update on Corporate Progress and 2013 Financial Results
|
|
Mar 13, 2014
|
MacroGenics Announces Date of Year End 2013 Financial Results Conference Call
|
|
Mar 06, 2014
|
MacroGenics Appoints Matthew Fust to Its Board of Directors
|
|
Mar 03, 2014
|
MacroGenics to Present at the 26th Annual ROTH Conference
|
|
Feb 12, 2014
|
MacroGenics Announces Pricing of Public Offering of Common Stock
|
|
Feb 10, 2014
|
MacroGenics Announces Proposed Public Offering of Common Stock
|
|
Feb 05, 2014
|
MacroGenics Achieves Milestone as Servier Exercises Option to Develop and Commercialize DART-Based Candidate, MGD006
|
|